Products for Research Use Only
RegisterLogin

SLx-2119 (KD025) 2mg

CAT: 0628-A15239-2Size: 2 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0628-A15239-2Size:2 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
911417-87-3

Chemical Information

2-(3-(4-(1H-Indazol-5-ylamino)-2-quinazolinyl)phenoxy)-N-(1-methylethyl)acetamide

Belumosudil is used in the treatment of chronic graft-versus-host disease (GVHD) and has been investigated for the treatment of pulmonary arterial hypertension. It is an inhibitor of rho-associated coiled-coil-containing protein kinases (ROCK), with significantly more selectivity for ROCK2 as compared to ROCK1 (IC50 100 nM vs. 3 μM, respectively). In the treatment of GVHD, a condition in which donor T-cells begin to attack recipient tissues following allogeneic hematopoeitic stem cell transplantation (HSCT), belumosudil helps to resolve immune dysregulation by shifting the balance between Th17 cells and T-regulatory cells, thereby dampening the inflammatory cascade that can occasionally be fatal. Belumosudil was first approved by the FDA in July 2021, under the brand name Rezurock, for the treatment of chronic GVHD in patients who have tried and failed at least two prior lines of systemic therapy. In July 2022, Belumosudil was approved by Health Canada under the brand name RHOLISTIQ to treat the same condition in adult and pediatric patients 12 years or older.

CAS Number911417-87-3
PubChem CID11950170
IUPAC Name2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-N-propan-2-ylacetamide
Molecular FormulaC26H24N6O2
Molecular Weight452.5
XLogP4.8
Topological Polar Surface Area105
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count7
Heavy Atom Count34
Formal Charge0
Complexity678
SMILES
CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5
InChI
InChI=1S/C26H24N6O2/c1-16(2)28-24(33)15-34-20-7-5-6-17(13-20)25-30-23-9-4-3-8-21(23)26(31-25)29-19-10-11-22-18(12-19)14-27-32-22/h3-14,16H,15H2,1-2H3,(H,27,32)(H,28,33)(H,29,30,31)
InChIKey
GKHIVNAUVKXIIY-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of 2-(3-(4-(1H-Indazol-5-ylamino)-2-quinazolinyl)phenoxy)-N-(1-methylethyl)acetamide
CAS: 911417-87-3
CID: 11950170
Formula: C26H24N6O2
MW: 452.5
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight452.5
XLogP34.8
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count7
Exact Mass452.19607403
Monoisotopic Mass452.19607403
Topological Polar Surface Area105 Ų
Heavy Atom Count34
Formal Charge0
Complexity678
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
A15239-50SLx-2119 (KD025) 50mg
A15239-500SLx-2119 (KD025) 500mg
A15239-25SLx-2119 (KD025) 25mg
A15239-10mM-DSLx-2119 (KD025) 10mM * 1mL in DMSO
A15239-10SLx-2119 10mg
A15239-5SLx-2119 5mg
A15239-100SLx-2119 100mg
A18324-2MTX-211 2mg
A16898-2LP-211 2mg
A24008-2YX968 2mg

Alternative Products

CatalogName
MBS3840950-01SLx-2119 (KD025)
MBS579393KD025 (SLx-2119)
A3825-25SLx-2119
MBS130623-01SLx-2119(KD-025)
GTR19159266-01KD025
S7936-5mgBelumosudil (KD025)
HY-158346RP-2119
BA8563-5MG-2119

Popular Products